Recombinant Anti-Ad fiber knob x Anti-CEA Bispecific Antibody (Diabody) is designed to be expressed as two polypeptide chains respectively. The two chains are cross-over pairing to form a dimer. Learn more about Ad fiber knob CEA Diabody: https://www.creative-biolabs.com/bsab/bispecific- #biotech
The microfluidic chips hold promise for convenient integration and have the ability to integrate a Polymerase Chain Reaction (PCR) module to add a critical missing component to the lab-on-a-chip (LOC) toolkit. Learn more about PCR microfluidic chip: https://microfluidics.creative-biolabs.com/polyme #biotech
IL-22 is a cytokine of the IL-10 family, which can be produced by T helper (Th) 17 cells, γδ T cells, natural killer T (NKT) cells, and the newly described innate lymphoid cells (ILCs). Since its discovery in 2000, the understanding of IL-22 biology has developed rapidly, and its role in many tissues has been confirmed, including the intestine, lung, liver, kidney, thymus, pancreas, and skin. Learn more about Introduction to IL-22: https://gammadelta-t-therapy.creative-biolabs.com #biotech
Derived from early blastocyst embryos, human embryonic stem cells (hESC) are self-renewable cells with pluripotency. Under special culture conditions, neural cells can be generated from hESC including glial cells, functional neurons, and oligodendrocytes. Learn more about ipsc neuroscience: https://neurost.creative-biolabs.com/custom-neura
Recombinant humanized antibody expressed in CHO binding to human TFPI. Concizumab is a monoclonal IgG4 antibody (mAb) that binds to the Kunitz-type protease inhibitor (KPI) 2 domain of TFPI thereby blocking the interaction of this domain with the active site of FXa. Learn more: https://www.creativebiolabs.net/Anti-TFPI-Therape
